COVID-19 Vaccination Program

Two companies – Pfizer and Moderna – have  applied for emergency use authorization from the U.S. Food and Drug Administration for their two-shot vaccine candidates, and more companies are expected to apply in the coming months. 

Our goal is to provide on-site COVID-19 shot clinics for companies, but we are waiting to learn more about how vaccine will be distributed across the country. With our 20+ years of experience with corporate flu shot clinics, we have a solid infrastructure that can be utilized for COVID-19 vaccination programs.

Here is what we know based on information from the CDC:

Limited COVID-19 vaccine is available now, but COVID-19 vaccine supply will increase substantially in the spring.

  • Initially available COVID-19 vaccines will either be approved as licensed vaccines or authorized for use under an Emergency Use Authorization (EUA) issued by the U.S Food and Drug Administration (FDA).
  • Cold chain storage and handling requirements for each COVID-19 vaccine product will vary from refrigerated (2° to 8°C) to frozen (-20°C) to ultra-cold (-60° to -80°C) temperatures. This could impact delivery to sites. 
  • For most vaccines, two doses of COVID-19 vaccine, separated by either 21 or 28 days, will be needed for immunity, and second-dose reminders for patients will be necessary. Both doses will need to match each other (i.e.,be the same vaccine product).

COVID-19 Vaccine Allocation

On November 6, CDC released executive summaries from the COVID-19 vaccine playbooks each state and jurisdiction submitted, a crucial step in the overall U.S. government effort to develop, distribute, and administer COVID-19 vaccines.  

The executive summaries provide an overview of how each state and jurisdiction is planning for the phases of COVID-19 vaccine distribution and administration.

The federal government will issue guidance on groups to prioritize for initial COVID-19 vaccination. On December 1, the Advisory Committee for Immunization Practices (ACIP) said health care workers and residents of nursing homes and other residential care facilities should be first in line to get COVID-19 vaccines.

Phase 1-A: Healthcare professionals who have potential for direct or indirect exposure to patients or infectious materials. 

Phase 1-B: Remainder of Phase 1-A, 1-B. Individuals living in long-term facilities including group homes.

It’s still unclear at this stage exactly when the vaccine will be made available to the general public – but most likely in spring 2021.

TotalWellness is ready to help.

Want to get first access?

Our COVID-19 Vaccine Program is in the works. 

Sign up now and we'll add to you to the list. You'll be the first to know when we launch.
Close Menu